The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124969432 12496943 2 F 201409 20160623 20160624 20160706 EXP GB-MHRA-ADR 23507035 GB-TEVA-669264ACC TEVA 47.00 YR F Y 63.50000 KG 20160706 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124969432 12496943 1 PS RAMIPRIL. RAMIPRIL 1 5 MILLIGRAM DAILY; 75 MG Y U 77470 5 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124969432 12496943 1 Hypertension

Outcome of event

Event ID CASEID OUTC COD
124969432 12496943 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124969432 12496943 Abnormal loss of weight
124969432 12496943 Alopecia
124969432 12496943 Arrhythmia
124969432 12496943 Arthralgia
124969432 12496943 Asthenia
124969432 12496943 Back pain
124969432 12496943 Balance disorder
124969432 12496943 Chest discomfort
124969432 12496943 Chest pain
124969432 12496943 Chills
124969432 12496943 Confusional state
124969432 12496943 Cough
124969432 12496943 Decreased appetite
124969432 12496943 Depression
124969432 12496943 Disturbance in attention
124969432 12496943 Dizziness
124969432 12496943 Dysgeusia
124969432 12496943 Dyspnoea
124969432 12496943 Eczema
124969432 12496943 Eye swelling
124969432 12496943 Fatigue
124969432 12496943 Gingival bleeding
124969432 12496943 Gingival recession
124969432 12496943 Heart rate increased
124969432 12496943 Heart rate irregular
124969432 12496943 Hot flush
124969432 12496943 Hyperhidrosis
124969432 12496943 Influenza like illness
124969432 12496943 Insomnia
124969432 12496943 Lacrimation increased
124969432 12496943 Mental impairment
124969432 12496943 Nervousness
124969432 12496943 Night sweats
124969432 12496943 Nocturia
124969432 12496943 Pain in extremity
124969432 12496943 Pain in jaw
124969432 12496943 Palpitations
124969432 12496943 Parosmia
124969432 12496943 Periodontitis
124969432 12496943 Pruritus
124969432 12496943 Rash papular
124969432 12496943 Red blood cell count decreased
124969432 12496943 Restlessness
124969432 12496943 Sinus disorder
124969432 12496943 Skin exfoliation
124969432 12496943 Sleep disorder
124969432 12496943 Slow response to stimuli
124969432 12496943 Swelling face
124969432 12496943 Throat irritation
124969432 12496943 Tinnitus
124969432 12496943 Tremor
124969432 12496943 Vision blurred

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124969432 12496943 1 20140916 20160331 0